Biomarkers, Cancer Therapy & Clinical Research
Biomarkers 2024
October 30-31, 2024 | Rome, Italy
Conference Series LLC Ltd welcomes you to attend the Biomarkers, Cancer Therapy & Clinical Research Conference to be held in Rome, Italy on October 30-31, 2024. The theme for the conference this year is Bio Markers: Exploring the Possibilities in Shaping the Future of Biomarkers.
Details of Biomarkers 2024 Conferences in Rome, Italy
Conference Name
|
Place
|
Date
|
Biomarkers 2024
|
Rome, Italy
|
October 30-31, 2024
|
Biomarkers 2024 Congress
Conference Series LLC Ltd cordially invites all the participants across the globe to attend the “19th World Congress on Biomarkers, Cancer Therapy & Clinical Research” during October 30-31, 2024 | Rome, Italy
Theme: Exploring the Possibilities in Shaping the Future of Biomarkers
Biomarker 2024 congress will enable to put forth the holistic scientific approach to validate the existing and development of novel biomarkers as to better understanding of diseases and diagnosis. The past six conference series of biomarkers meeting have grounded the best possible researchers in the field of biomarkers from diverse scientific disciplines, and so will be the upcoming.
Biomarkers are important for streamlining drug discovery and development. In addition, biomarkers can be widely used as a tool for disease diagnosis, personalized medication in clinical research. Study design and statistical analysis for biomarker research incorporates various tools from bioinformatics. It further involves patient segmentation and stratification by successful integration of diagnostic tools and clinical data annotation inclusive of classification distribution metrics and pattern recognition. The global market for biomarkers in data statistics is estimated at about $2.4 billion in 2011 and further projected to reach $7.6 billion by 2017 registering a CAGR of 18.3% during the period 2007-2017. The organizations involved are Affymetrix, Agilent Technologies, Biomax Informatics, Illumina, Qiagen etc amongst others across the globe.
Conference Series LLC Ltd organizes 3000+ Global events in conference series every year across the globe with support from 1000+ more scientific societies and Publishes 700 Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With individuals around the globe concentrated on finding out about Biomarkers, Cancer Therapy and Clinical Research; this is your best chance to achieve the biggest gathering of members from the Biomarkers and Clinical Research people group. Direct presentations, circulate data, meet with present and potential researchers, make a sprinkle with cutting edge medicines, and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest procedures, advancements and the most current upgrades in Biomarkers, Cancer Theraphy and Clinical Research are the signs of this gathering.
Target Audience:
-
Biomarkers and Clinical Research Scientists, Students
-
Biomarkers, Cancer Therapy and Clinical Researchers
-
Medical Colleges
-
Psychiatrists
-
Biomarkers and Clinical Research Associations and Societies
-
Business Entrepreneurs
-
Software developing companies
-
Manufacturing Medical Devices Companies
-
Cancer Researchers
-
Data Management Companies
-
Pharmaceutical Companies
-
Diagnostics
Past Conference Report
The success of the Biomarkers, Cancer Therapy & Clinical Research has given us the prospect to bring the gathering one more time in Vancouver, Canada during September 27-28, 2023. Biomarkers Congress meeting engrossed a vicinity of comprehensive discussions on novel subjects like Biomarkers, Functional Genomics and Cytogenetic Biomarkers, Biomarkers in Clinical Research and Development, Biomarkers for Disorders, Techniques to Maximize Biomarker Identification, Biomarkers in Nano science, Cancer Biomarkers, Functional Transcriptomics and Profiling Techniques, Biomarkers in Toxicology, Biomarkers in Microbial Infections, Biomarkers in Drug Discovery
Biomarkers 2023 extends its warm gratitude to all the previous year’s Honourable Guest and Keynote Speakers of the event:
Biomarkers 2015 | September 01-02, 2015 | Toronto, Canada
-
Trevor G Marshall, Autoimmunity Research Foundation, USA
-
Claude Prigent, Institute of Genetics and Development of Rennes, France
-
Biswendu B Goswami, FDA Center for Food Safety and Applied Nutrition, USA
-
Sergey Suchkov, I.M.Sechenov First Moscow State Medical University, Russia
-
Alain Moreau, Sainte-Justine University Hospital, Canada
-
Chee Gee See, Proteome Sciences, UK
-
Martin Weber, Austrian Institute of Technology GmbH, Austria
-
Marsha A Moses, Harvard Medical School, USA
-
Jan Voskuil, Everest Biotech Ltd., UK
-
Scott Marshall, Precision for Medicine, USA
Biomarkers 2016 | December 05-07, 2016 | Philadelphia, Pennsylvania, USA
-
Huber Colleen, Naturopathic Oncology Research Institute, USA
-
Chen Song, Harvard Medical School, USA
-
Ying Mu, Center for Devices and Radiological Health-US FDA, USA
-
Al Charest, Beth Israel Deaconess Medical Center Cancer Center, USA
-
Jianyu Rao, David Geffen School of Medicine-UCLA, USA
-
Andrea Nicolini, University of Pisa, Italy
-
Hideshi Ishii, Osaka University Graduate School of Medicine, Japan
-
Erik Andrade Jorge, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico
-
Jose Guadalupe Trujillo Ferrara, Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico
-
Cheryl McAlpine, Immunocore Ltd., UK
Biomarkers 2017 | October 18-20, 2017 | Baltimore, Maryland, USA
-
Frédéric Baribaud, Johnson & Johnson, USA
-
David Dongliang Ge, Apostle Inc, USA
-
Kamala K Maddali, Cancer Genetics Inc, USA
-
Yoshiaki Omura, New York Medical College, USA
-
Diana Anderson, University of Bradford, UK
-
Srinivas Pentyala, Stony Brook Medical Center, USA
-
Jianhua Luo, University of Pittsburgh, USA
-
Michael Retsky, Harvard School of Public Health, USA
-
David I Smith, Mayo Clinic, USA
-
John Michael Sauer, University of Arizona College of Medicine, USA
-
Nikolai V Ivanov, Philip Morris International Research & Development, Switzerland
-
Lowe Leroy, Lancaster University, UK
-
George Vasmatzise, Mayo Clinic, USA
-
Sergey Suchkov, I M Sechenov First Moscow State Medical University, Russia
-
Qing Kay Li, Johns Hopkins Medical Institutions, USA
Biomarkers 2018 | October 03-04, 2018 | Los Angeles, California, USA
-
Michael Retsky, Harvard TH Chan School of Public Health, USA
-
Jianhua Luo, University of Pittsburgh School of Medicine, USA
-
Li Zhang, The University of Texas at Dallas, USA
-
Diana Anderson, University of Bradford, UK
-
Magnus S Magnusson, University of Iceland, Iceland
-
P Schulz-Knappe, Protagen AG, Germany
-
George Vasmatzis, Mayo Clinic, USA
-
Huihuang Yan, Mayo Clinic, USA
-
Yoshiaki Omura, New York Medical College, USA
-
Sushma Umrao, Danal Al Emarat Hospital, UAE
-
Bing li, University of Louisville, USA
-
Katarína Janšáková, Comenius University, Slovakia
Biomarkers management teams offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with ConferenceSeries Ltd and supported the conference in every aspect.
Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Biomarkers 2015, Biomarkers 2016, Biomarkers 2017, Biomarkers 2018, Biomarkers 2024. Conference Series LLC Ltd would like to announce the commencement of the “19th World Congress on Biomarkers, Cancer Therapy & Clinical Research” to be held during June 27-28, 2024 |London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Biomarkers, Cancer Therapy & Clinical Research.
Let us meet again @ Biomarkers 2024
VISA-TripAdvisor
Planning a Trip to London, UK !!! Attending Meeting!!!
An issue with VISA!!
Biomarkers 2024 Committee will be happy to help you in all regards to plan your trip to Vancouver, Canada. Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA.
Find out what you need to do to visit Canada as a tourist or business person, how to extend your stay in Canada and what documents you need to carry with you to transit through Canada.
Application submission:
Canada does not have a visa office in every country so it is important that Delegates/Attendees visit the website of the visa office responsible for processing their visa applications. Information is available on the website on how to submit a visa application and the documentation required.
Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications (e-Apps).
E-Apps
This system allows clients to submit applications online.
Delegates/Attendees that need a visa but require their passport for other travel purposes are strongly encouraged to submit their visa applications online (e-Apps). Delegates/Attendees that choose to apply online will not have to submit their passport until a decision has been taken on their applications. If required, the visa office will send the applicant instructions on how and where to send their passports to finalize the visa process.
Visa Application Centers (VACs):
VACs are commercial service providers authorized by Canada to provide specific services to applicants.
VACs provide a number of services including help applicants fill out forms, answer questions and ensure that applications are complete, thereby reducing unnecessary delays or refusals due to incomplete applications.
Applicants that are required to provide biometrics information as part of the visa application process can do so at a VAC. Additional information on the biometrics requirements is available at the IRCC website.
VACs send applications to Visa Offices and transmit decisions to applicants in a secure and confidential manner. VACs do not process visa applications and play no role in the decision-making process.
Visa Applications Processing Time:
Processing time for visa applications vary depending on the office and the time of the year. Participants should be encouraged to apply early for their visas, and to submit complete applications including all supporting documents.
Please visit the IRCC website for information on the time it takes to process visa applications at the various visa offices.
NEW - Electronic Travel Authorization (eTA)
As of March 15, 2016, visa-exempt foreign nationals are expected to have an Electronic Travel Authorization (eTA) to fly to or transit through Canada. Exceptions include U.S. citizens and travelers with a valid Canadian visa. Canadian citizens, including dual citizens, and Canadian permanent residents are not eligible to apply for an eTA.
However, from March 15, 2016, until fall 2016, travellers who do not have an eTA can board their flight, as long as they have appropriate travel documents, such as a valid passport. During this time, border services officers can let travellers arriving without an eTA into the country, as long as they meet the other requirements to enter Canada. We invite you to consult the IRCC website regularly for information updates on eTA.
Best Tourist Destination: Vancouver
-
Stanley Park
-
Granville Island
-
Grouse Mountain
-
Museum of Anthropology
-
Kitsilano Beach
-
Gastown
-
Canada Place
-
Chinatown
-
English Bay
-
Capilano Suspension Bridge
-
Robson Street
-
Museum of Vancouver
-
Queen Elizabeth Park
-
Science World
-
Richmond & Many more…